OR WAIT 15 SECS
© 2020 MJH Life Sciences and BioPharm International. All rights reserved.
July 01, 2020
FDA can better monitor quality production of domestic versus foreign firms.
June 01, 2020
FDA and the US Congress support innovation and access to cheaper medicines.
May 01, 2020
Policy makers seek to ensure supplies of new therapies and to limit shortages.
April 01, 2020
FDA is encouraging alternative insulins and challenging anticompetitive practices.
March 01, 2020
States, hospitals, and insurers support manufacturing arrangements to ensure access to affordable medicines.
February 01, 2020
Increased reliance on foreign producers raises concerns and spurs collaborations.
January 01, 2020
Pressures on FDA will affect industry’s success in bringing new therapies to market.
November 01, 2019
FDA readies more efficient oversight processes while advancing collaboration with Europe.
October 01, 2019
Falsified documents and manipulated test results prompt warnings and investigations.
September 01, 2019
Industry and regulators seek global system that reduces regional differences.